AAAAAA

   
Results: 1-22 |
Results: 22
HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE AND THIOTEPA PLUS PBSC IN PATIENTS WITH METASTATIC BREAST-CANCER RESPONDING TO INDUCTION CHEMOTHERAPY
Authors: ROSTI G TIENGHI A VERTOGEN B GIOVANIS P CARIELLO A SABBATINI R RIGGI G MARANGOLO M
Citation: G. Rosti et al., HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE AND THIOTEPA PLUS PBSC IN PATIENTS WITH METASTATIC BREAST-CANCER RESPONDING TO INDUCTION CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 117-117
NONMETASTATIC EWINGS-SARCOMA - PRELIMINARY-RESULTS OF A PROTOCOL WITHIFOSFAMIDE SINCE THE INDUCTION-PHASE ADDED TO VINCRISTINE, DOXORUBICIN, ACTINOMYCIN-D, CYCLOPHOSPHAMIDE AND ETOPOSIDE
Authors: FERRARI S BACCI G MERCURI M BERTONI F PICCI P BARBIERI E ROSITO P DELPREVER AB TIENGHI A COMANDONE A
Citation: S. Ferrari et al., NONMETASTATIC EWINGS-SARCOMA - PRELIMINARY-RESULTS OF A PROTOCOL WITHIFOSFAMIDE SINCE THE INDUCTION-PHASE ADDED TO VINCRISTINE, DOXORUBICIN, ACTINOMYCIN-D, CYCLOPHOSPHAMIDE AND ETOPOSIDE, Annals of oncology, 9, 1998, pp. 554-554
COMBINED TREATMENT IN OSTEOSARCOMA OF THE JAWS
Authors: TIENGHI A MARCHETTI C MARANGOLO M GALLIANI E GIOVANIS P CARIELLO A DALLERA P
Citation: A. Tienghi et al., COMBINED TREATMENT IN OSTEOSARCOMA OF THE JAWS, Annals of oncology, 9, 1998, pp. 573-573
A SEQUENTIAL CHEMO-RADIOTHERAPEUTIC TREATMENT FOR ANAPLASTIC GLIOMAS - A PHASE-II PILOT-STUDY
Authors: DAZZI C CARIELLO A GIANNINI M GIOVANIS P FIORENTINI G LEONI M ROSTI G TURCI D TIENGHI A MARANGOLO M
Citation: C. Dazzi et al., A SEQUENTIAL CHEMO-RADIOTHERAPEUTIC TREATMENT FOR ANAPLASTIC GLIOMAS - A PHASE-II PILOT-STUDY, Annals of oncology, 9, 1998, pp. 635-635
PREDICTIVE FACTORS OF HISTOLOGIC RESPONSE TO PRIMARY CHEMOTHERAPY IN OSTEOSARCOMA OF THE EXTREMITY - STUDY OF 272 PATIENTS PREOPERATIVELY TREATED WITH HIGH-DOSE METHOTREXATE, DOXORUBICIN, AND CISPLATIN
Authors: BACCI G FERRARI S DELEPINE N BERTONI F PICCI P MERCURI M BACCHINI P DELPREVER AB TIENGHI A COMANDONE A CAMPANACCI M
Citation: G. Bacci et al., PREDICTIVE FACTORS OF HISTOLOGIC RESPONSE TO PRIMARY CHEMOTHERAPY IN OSTEOSARCOMA OF THE EXTREMITY - STUDY OF 272 PATIENTS PREOPERATIVELY TREATED WITH HIGH-DOSE METHOTREXATE, DOXORUBICIN, AND CISPLATIN, Journal of clinical oncology, 16(2), 1998, pp. 658-663
NEOADJUVANT CHEMOTHERAPY FOR EXTREMITY OSTEOSARCOMA - PRELIMINARY-RESULTS OF THE RIZZOLIS 4TH STUDY
Authors: BACCI G FERRARI S MERCURI M LONGHI A CAPANNA R TIENGHI A DELPREVER AB COMANDONE A CESARI M BERNINI G PICCI P
Citation: G. Bacci et al., NEOADJUVANT CHEMOTHERAPY FOR EXTREMITY OSTEOSARCOMA - PRELIMINARY-RESULTS OF THE RIZZOLIS 4TH STUDY, Acta oncologica, 37(1), 1998, pp. 41-48
INFLAMMATORY BREAST-CANCER (IBC) TREATED WITH HIGH-DOSE CHEMOTHERAPY PLUS PBSC SUPPORT - AN ITALIAN MULTICENTER STUDY
Authors: TIENGHI A MARANGOLO M VERTOGEN B MOLINO AM LELLI G SABBATINI R FERRANTE P CARIELLO A ROSTI G
Citation: A. Tienghi et al., INFLAMMATORY BREAST-CANCER (IBC) TREATED WITH HIGH-DOSE CHEMOTHERAPY PLUS PBSC SUPPORT - AN ITALIAN MULTICENTER STUDY, Bone marrow transplantation, 21, 1998, pp. 224-224
NEOADJUVANT CHEMOTHERAPY FOR EWINGS-SARCOMA OF BONE - NO BENEFIT OBSERVED AFTER ADDING IFOSFAMIDE AND ETOPOSIDE TO VINCRISTINE, ACTINOMYCIN, CYCLOPHOSPHAMIDE, AND DOXORUBICIN IN THE MAINTENANCE PHASE - RESULTSOF 2 SEQUENTIAL STUDIES
Authors: BACCI G PICCI P FERRARI S MERCURI M DELPREVER AB ROSITO P BARBIERI E TIENGHI A FORNI C
Citation: G. Bacci et al., NEOADJUVANT CHEMOTHERAPY FOR EWINGS-SARCOMA OF BONE - NO BENEFIT OBSERVED AFTER ADDING IFOSFAMIDE AND ETOPOSIDE TO VINCRISTINE, ACTINOMYCIN, CYCLOPHOSPHAMIDE, AND DOXORUBICIN IN THE MAINTENANCE PHASE - RESULTSOF 2 SEQUENTIAL STUDIES, Cancer, 82(6), 1998, pp. 1174-1183
NEOADJUVANT CHEMOTHERAPY FOR OSSEOUS MALIGNANT FIBROUS HISTIOCYTOMA OF THE EXTREMITY - RESULTS IN 18 CASES AND COMPARISON WITH 112 CONTEMPORARY OSTEOSARCOMA PATIENTS TREATED WITH THE SAME CHEMOTHERAPY REGIMEN
Authors: BACCI G FERRARI S BERTONI F MERCURI M FORNI C SOTTILI S GASBARRINI A TIENGHI A CESARI M CAMPANACCI M
Citation: G. Bacci et al., NEOADJUVANT CHEMOTHERAPY FOR OSSEOUS MALIGNANT FIBROUS HISTIOCYTOMA OF THE EXTREMITY - RESULTS IN 18 CASES AND COMPARISON WITH 112 CONTEMPORARY OSTEOSARCOMA PATIENTS TREATED WITH THE SAME CHEMOTHERAPY REGIMEN, Journal of chemotherapy, 9(4), 1997, pp. 293-299
LONG-TERM FOLLOW-UP AND POST-RELAPSE SURVIVAL IN PATIENTS WITH NONMETASTATIC OSTEOSARCOMA OF THE EXTREMITY TREATED WITH NEOADJUVANT CHEMOTHERAPY
Authors: FERRARI S BACCI G PICCI P MERCURI M BRICCOLI A PINTO D GASBARRINI A TIENGHI A DELPREVER AB
Citation: S. Ferrari et al., LONG-TERM FOLLOW-UP AND POST-RELAPSE SURVIVAL IN PATIENTS WITH NONMETASTATIC OSTEOSARCOMA OF THE EXTREMITY TREATED WITH NEOADJUVANT CHEMOTHERAPY, Annals of oncology, 8(8), 1997, pp. 765-771
CHEMOTHERAPY-INDUCED TUMOR NECROSIS AS A PROGNOSTIC FACTOR IN LOCALIZED EWINGS-SARCOMA OF THE EXTREMITIES
Authors: PICCI P BOHLING T BACCI G FERRARI S SANGIORGI L MERCURI M RUGGIERI P MANFRINI M FERRARO A CASADEI R BENASSI MS MANCINI AF ROSITO P CAZZOLA A BARBIERI E TIENGHI A DELPREVER AB COMANDONE A BACCHINI P BERTONI F
Citation: P. Picci et al., CHEMOTHERAPY-INDUCED TUMOR NECROSIS AS A PROGNOSTIC FACTOR IN LOCALIZED EWINGS-SARCOMA OF THE EXTREMITIES, Journal of clinical oncology, 15(4), 1997, pp. 1553-1559
THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTORS FOLLOWING PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE AFTER HIGH-DOSE CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A PROSPECTIVE-STUDY
Authors: DAZZI C ALBERTAZZI L ROSTI G MAESTRI A FIORENTINI G LEONI M TIENGHI A TURCI D FERRANTE P VERTOGEN B CARIELLO A LATINO W ZUMAGLINI F MARANGOLO M
Citation: C. Dazzi et al., THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTORS FOLLOWING PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE AFTER HIGH-DOSE CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A PROSPECTIVE-STUDY, Tumori, 83(6), 1997, pp. 900-903
PACLITAXEL PLUS DOXORUBICIN IN BREAST-CANCER - AN ITALIAN EXPERIENCE
Authors: FRASSINETI GL ZOLI W SILVESTRO L SERRA P MILANDRI C TIENGHI A GIANNI L GENTILE A SALZANO E AMADORI D
Citation: Gl. Frassineti et al., PACLITAXEL PLUS DOXORUBICIN IN BREAST-CANCER - AN ITALIAN EXPERIENCE, Seminars in oncology, 24(5), 1997, pp. 19-25
HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLO OD PROGENITOR CELLS WITH RESPECT TO SOLID TUMORS
Authors: ROSTI G FERRANTE P TIENGHI A TURCI D DAZZI C LEONI M FIORENTINI G FERRARI E ZORNETTA L MARANGOLO M
Citation: G. Rosti et al., HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLO OD PROGENITOR CELLS WITH RESPECT TO SOLID TUMORS, Tumori, 82(2), 1996, pp. 19-22
THE SEQUENTIAL ADMINISTRATION OF COMBINED DOXORUBICIN AND PACLITAXEL IN THE TREATMENT OF ADVANCED BREAST-CANCER
Authors: FRASSINETI GL ZOLI W TIENGHI A RAVAIOLI A MILANDRI C GENTILE A SALZANO E AMADORI D
Citation: Gl. Frassineti et al., THE SEQUENTIAL ADMINISTRATION OF COMBINED DOXORUBICIN AND PACLITAXEL IN THE TREATMENT OF ADVANCED BREAST-CANCER, Seminars in oncology, 23(5), 1996, pp. 22-28
A PHASE I II STUDY OF SEQUENTIAL DOXORUBICIN AND PACLITAXEL IN THE TREATMENT OF ADVANCED BREAST-CANCER/
Authors: AMADORI D FRASSINETI GL ZOLI W MILANDRI C TIENGHI A RAVAIOLI A GENTILE A SALZANO E
Citation: D. Amadori et al., A PHASE I II STUDY OF SEQUENTIAL DOXORUBICIN AND PACLITAXEL IN THE TREATMENT OF ADVANCED BREAST-CANCER/, Seminars in oncology, 23(5), 1996, pp. 16-22
A PHASE I II STUDY OF PACLITAXEL AND DOXORUBICIN IN THE TREATMENT OF ADVANCED BREAST-CANCER/
Authors: AMADORI D FRASSINETI GL ZOLI W TIENGHI A RAVAIOLI A GIUNCHI DC GENTILE A SALZANO E
Citation: D. Amadori et al., A PHASE I II STUDY OF PACLITAXEL AND DOXORUBICIN IN THE TREATMENT OF ADVANCED BREAST-CANCER/, Seminars in oncology, 23(1), 1996, pp. 19-23
CHANGING PATTERN OF RELAPSE IN OSTEOSARCOMA OF THE EXTREMITIES TREATED WITH ADJUVANT AND NEOADJUVANT CHEMOTHERAPY
Authors: BACCI G RUGGIERI P PICCI P BRICCOLI A FERRARO A FERRARI S TIENGHI A IANTORNO D CAMPANACCI M
Citation: G. Bacci et al., CHANGING PATTERN OF RELAPSE IN OSTEOSARCOMA OF THE EXTREMITIES TREATED WITH ADJUVANT AND NEOADJUVANT CHEMOTHERAPY, Journal of chemotherapy, 7(3), 1995, pp. 230-239
INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL
Authors: DELTURCO MR PALLI D CARIDDI A CIATTO S PACINI P DISTANTE V AZZINI V BELSANTI V BARTOLUCCI R DICOSTANZO F BERTUSI M DANESE S GIARDINA G DAIUTO G UCCELLO V DELEO G PUNZO C GOSSO P GRISO C LOCATELLI E MANSUTTI M SANDRI P MOLINO AM SCHINCAGLIA P TIENGHI A
Citation: Mr. Delturco et al., INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL, JAMA, the journal of the American Medical Association, 271(20), 1994, pp. 1593-1597
INFLUENCE OF ADRIAMYCIN DOSE IN THE OUTCOME OF PATIENTS WITH OSTEOSARCOMA TREATED WITH MULTIDRUG NEOADJUVANT CHEMOTHERAPY - RESULTS OF 2 SEQUENTIAL STUDIES
Authors: BACCI G PICCI P FERRARI S CASADEI R DELPREVER AB TIENGHI A MANCINI A
Citation: G. Bacci et al., INFLUENCE OF ADRIAMYCIN DOSE IN THE OUTCOME OF PATIENTS WITH OSTEOSARCOMA TREATED WITH MULTIDRUG NEOADJUVANT CHEMOTHERAPY - RESULTS OF 2 SEQUENTIAL STUDIES, Journal of chemotherapy, 5(4), 1993, pp. 237-246
NO ADVANTAGES IN THE ADDITION OF IFOSFAMIDE AND VP-16 TO THE STANDARD4-DRUG REGIMEN IN THE MAINTENANCE PHASE OF NEOADJUVANT CHEMOTHERAPY OF EWINGS-SARCOMA OF BONE - RESULTS OF 2 SEQUENTIAL STUDIES
Authors: BACCI G PICCI P RUGGIERI P FERRARI S MERCURI M FABBRI N ROSITO P BARBIERI E FERRARO A CASADEI R DELPREVER AB TIENGHI A CAZZOLA A CAMPANACCI M
Citation: G. Bacci et al., NO ADVANTAGES IN THE ADDITION OF IFOSFAMIDE AND VP-16 TO THE STANDARD4-DRUG REGIMEN IN THE MAINTENANCE PHASE OF NEOADJUVANT CHEMOTHERAPY OF EWINGS-SARCOMA OF BONE - RESULTS OF 2 SEQUENTIAL STUDIES, Journal of chemotherapy, 5(4), 1993, pp. 247-257
PRIMARY CHEMOTHERAPY AND DELAYED SURGERY FOR NONMETASTATIC OSTEOSARCOMA OF THE EXTREMITIES - RESULTS IN 164 PATIENTS PREOPERATIVELY TREATEDWITH HIGH-DOSES OF METHOTREXATE FOLLOWED BY CISPLATIN AND DOXORUBICIN
Authors: BACCI G PICCI P FERRARI S RUGGIERI P CASADEI R TIENGHI A DELPREVER AB GHERLINZONI F MERCURI M MONTI C
Citation: G. Bacci et al., PRIMARY CHEMOTHERAPY AND DELAYED SURGERY FOR NONMETASTATIC OSTEOSARCOMA OF THE EXTREMITIES - RESULTS IN 164 PATIENTS PREOPERATIVELY TREATEDWITH HIGH-DOSES OF METHOTREXATE FOLLOWED BY CISPLATIN AND DOXORUBICIN, Cancer, 72(11), 1993, pp. 3227-3238
Risultati: 1-22 |